Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (20,8 Mio. €): COllaborative Management Platform zur Erkennung und Analyse von (Re-)neu aufkommenden und lebensmittelbedingten Ausbrüchen in Europa Hor01.12.2014 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

COllaborative Management Platform zur Erkennung und Analyse von (Re-)neu aufkommenden und lebensmittelbedingten Ausbrüchen in Europa

COMPARE aims to harness the rapid advances in molecular technology to improve identification and mitigation of emerging infectious diseases and foodborne outbreaks. To this purpose COMPARE will establish a “One serves all” analytical framework and data exchange platform that will allow real time analysis and interpretation of sequence-based pathogen data in combination with associated data (e.g. clinical, epidemiological data) in an integrated inter-sectorial, interdisciplinary, international, “one health” approach. The framework will link research, clinical and public health organisations active in human health, animal health, and food safety in Europe and beyond, to develop (i) integrated risk assessment and risk based collection of samples and data, (ii) harmonised workflows for generating comparable sequence and associated data, (iii) state-of-the-art analytical workflows and tools for generating actionable information for support of patient diagnosis, treatment, outbreak detection and -investigation and (iv) risk communication tools. The analytical workflows will be linked to a flexible, scalable and open-source data- and information platform supporting rapid sharing, interrogation and analysis of sequence-based pathogen data in combination with other associated data. The system will be linked to existing and future complementary systems, networks and databases such as those used by ECDC, NCBI and EFSA. The functionalities of the system will be tested and fine tuned through underpinning research studies on priority pathogens covering healthcare-associated infections, food-borne disease, and (zoonotic) (re-) emerging diseases with epidemic or pandemic potential. Throughout the project, extensive consultations with future users, studies into the barriers to open data sharing, dissemination and training activities and studies on the cost-effectiveness of the system will support future sustainable user uptake.


Geförderte Unternehmen:

Firmenname Förderungssumme
Agence Nationale de la Securite Sanitaire de L Alimentation de L Environnement et du Travail 601.250 €
Alma Mater Studiorum - Universita Di Bologna 434.181 €
Aristotelio Panepistimio Thessalonikis 353.750 €
Artemis BIO-Support B.V. 306.250 €
Charite - Universitaetsmedizin Berlin 231.583 €
Civic Consulting GmbH 434.531 €
Danmarks Tekniske Universitet 3.006.000 €
Erasmus Universitair Medisch Centrum Rotterdam 2.656.641 €
Erasmus Universiteit Rotterdam 438.516 €
European Molecular Biology Laboratory 1.950.000 €
Fondation Merieux 428.830 €
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit 1.000.000 €
Genome Research Ltd. LBG 200.000 €
HUN-REN Wigner Fizikai Kutatokozpont 403.750 €
Institut Francais de Recherche Pour l'Exploitation de la mer 401.808 €
Istituto Superiore Di Sanita 603.125 €
Leibniz-Institut DSMZ-Deutsche Sammlung VON Mikroorganismen UND Zellkulturen GmbH 403.770 €
Responsible Technology 411.388 €
Rijksinstituut Voor Volksgezondheid EN Milieu 759.500 €
Robert Koch-Institut 718.000 €
Statens Serum Institut 919.750 €
Stichting Amsterdam UMC 602.795 €
Stiftung Tieraerztliche Hochschule Hannover 403.750 €
THE Australian National University 0,00 €
The Chancellor Masters and Scholars of the University of Cambridge 504.058 €
The Secretary of State for Environment, Food and Rural Affairs 971.361 €
The University of Edinburgh 697.259 €
Universidad de Castilla - La Mancha 400.750 €
Universitatsklinikum Bonn 172.675 €
Universiteit Antwerpen 402.500 €

Quelle: https://cordis.europa.eu/project/id/643476

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.